Factor XI (FXI) is the zymogen precursor of an active serine protease that participates in the contact phase of coagulation. Synthesized in the liver, it circulates in the plasma in a noncovalent complex with high molecular weight kininogen (1) at a normal concentration of 5 μg/mL. (For clinical purposes, the normal range is defined as 50-150 U/dL) (2). FXI circulates as a homodimeric glycoprotein with a mass of 160 kDa
In factor XI (FXI) deficiency, bleeding cannot be predicted by routine analyses. Since FXI is involv...
bleeding disorder, is rare worldwide but common in Jews in whom 2 mutations, Glu117Stop (type II) an...
Essentials Plasma of factor XI-deficient patients (FXI-dp) displays enhanced fibrinolysis. We invest...
Factor XI (FXI) is a serine protease involved in the propagation phase of coagulation and in providi...
Human factor XI (FXI) is a blood coagulation factor participat-ing in the early phase of the intrins...
Coagulation factor XI (FXI) is the zymogen of a serine protease that, when converted to its active f...
Coagulation factor XI (FXI) is the zymogen of a serine protease that, when converted to its active f...
The bleeding diathesis associated with hereditary factor XI (fXI) deficiency is prevalent in Ashkena...
PCR-SSCP and DNA sequence analysis of a factor XI (FXI) deficient patient (FXI:C 39 U/dL; FXI:Ag 27 ...
Severe factor XI (FXI) deficiency is an injury-related bleeding disorder, common in Ashkenazi Jews a...
Severe factor XI (FXI) deficiency is a bleeding disorder generally inherited as an autosomal recessi...
Background In factor XI (FXI) deficiency, bleeding cannot be predicted by routine analyses. Since FX...
The management of factor XI deficiency is not straightforward for three reasons: firstly, the role o...
The contributions of coagulation factor XI (FXI) and FXII to human clot formation is not fully known...
International audienceBleeding risk is not predictable in patients with factor XI (FXI; F11) deficie...
In factor XI (FXI) deficiency, bleeding cannot be predicted by routine analyses. Since FXI is involv...
bleeding disorder, is rare worldwide but common in Jews in whom 2 mutations, Glu117Stop (type II) an...
Essentials Plasma of factor XI-deficient patients (FXI-dp) displays enhanced fibrinolysis. We invest...
Factor XI (FXI) is a serine protease involved in the propagation phase of coagulation and in providi...
Human factor XI (FXI) is a blood coagulation factor participat-ing in the early phase of the intrins...
Coagulation factor XI (FXI) is the zymogen of a serine protease that, when converted to its active f...
Coagulation factor XI (FXI) is the zymogen of a serine protease that, when converted to its active f...
The bleeding diathesis associated with hereditary factor XI (fXI) deficiency is prevalent in Ashkena...
PCR-SSCP and DNA sequence analysis of a factor XI (FXI) deficient patient (FXI:C 39 U/dL; FXI:Ag 27 ...
Severe factor XI (FXI) deficiency is an injury-related bleeding disorder, common in Ashkenazi Jews a...
Severe factor XI (FXI) deficiency is a bleeding disorder generally inherited as an autosomal recessi...
Background In factor XI (FXI) deficiency, bleeding cannot be predicted by routine analyses. Since FX...
The management of factor XI deficiency is not straightforward for three reasons: firstly, the role o...
The contributions of coagulation factor XI (FXI) and FXII to human clot formation is not fully known...
International audienceBleeding risk is not predictable in patients with factor XI (FXI; F11) deficie...
In factor XI (FXI) deficiency, bleeding cannot be predicted by routine analyses. Since FXI is involv...
bleeding disorder, is rare worldwide but common in Jews in whom 2 mutations, Glu117Stop (type II) an...
Essentials Plasma of factor XI-deficient patients (FXI-dp) displays enhanced fibrinolysis. We invest...